Julio A. Ramirez, M.D., FACP
![]() |
Julio A. Ramirez, M.D., FACP
401 East Chestnut Street, Ste. 310 Louisville, KY 40202 502-852-5131 - Academic Office |
Clinical Expertise
Infectious Diseases
Board Certifications
-
American Board of Internal Medicine - Internal Medicine / Infectious Disease
Education and Training
-
Medical School: La Plata National University, School of Medical Science
-
Residency: La Plata National University, Postgraduate Medical School; Lincoln Medical Center, New York Medical College
-
Fellowship: National Institute of Respiratory Diseases and Thoracic Surgery, University of Chile; University of Louisville
Recent Publications
-
Haque NZ, Arshad S, Peyrani P, Ford KD, Perri MB, Jacobsen G, Reyes K, Scerpella EG, Ramirez JA, Zervos MJ. Analysis of pathogen and host factors related to clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2012 Feb 15. [Epub ahead of print].
-
Borel N, Pospischil A, Dowling RD, Dumrese C, Gaydos CA, Bunk S, Hermann C, Ramirez JA, Summersgill JT. Antigens of persistent Chlamydia pneumoniae within coronary atheroma from patients undergoing heart transplantation. J Clin Pathol. 2012 Feb;65(2):171-7. Epub 2011 Nov 2.
-
Cano EL, Haque NZ, Welch VL, Cely CM, Peyrani P, Scerpella EG, Ford KD, Zervos MJ, Ramirez JA, Kett DH; Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Study Group. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database. Clin Ther. 2012 Jan;34(1):149-57.
-
Brock GN, Barnes C, Ramirez JA, Myers J. How to handle mortality when investigating length of hospital stay and time to clinical stability. BMC Med Res Methodol. 2011 Oct 26;11:144.
-
Peyrani P, Allen M, Wiemken TL, Haque NZ, Zervos MJ, Ford KD, Scerpella EG, Mangino JE, Kett DH, Ramirez JA; IMPACT-HAP Study Group. Severity of disease and clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus strains not influenced by the presence of the Panton-Valentine Leukocidin gene. Clin Infect Dis. 2011 Oct;53(8):766-71. Epub 2011 Aug 31.
-
Wiemken TL, Ramirez JA, Polgreen P, Peyrani P, Carrico RM. Evaluation of the knowledge-sharing social network of hospital-based infection preventionists in Kentucky. Am J Infect Control. 2011 Aug 30. [Epub ahead of print].
-
Aliberti S, Peyrani P, Filardo G, Mirsaeidi M, Amir A, Blasi F, Ramirez JA. Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia. Chest. 2011 Aug;140(2):482-8. Epub 2011 Feb 17.
-
Kasuya Y, Hargett JL, Lenhardt R, Heine MF, Doufas AG, Remmel KS, Ramirez JA, Akça O. Ventilator-associated pneumonia in critically ill stroke patients: frequency, risk factors, and outcomes. J Crit Care. 2011 Jun;26(3):273-9. Epub 2010 Nov 23.
-
Kett DH, Cano E, Quartin AA, Mangino JE, Zervos MJ, Peyrani P, Cely CM, Ford KD, Scerpella EG, Ramirez JA; Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Investigators. Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Lancet Infect Dis. 2011 Mar;11(3):181-9. Epub 2011 Jan 20.
-
Mangino JE, Peyrani P, Ford KD, Kett DH, Zervos MJ, Welch VL, Scerpella EG,Ramirez JA; IMPACT-HAP Study Group. Development and implementation of a performance improvement project in adult intensive care units: overview of the Improving Medicine Through Pathway Assessment of Critical Therapy in Hospital-Acquired Pneumonia (IMPACT-HAP) study. Crit Care. 2011;15(1):R38. Epub 2011 Jan 25.


Previous:
Paula Peyrani, M.D.

